SCHEMBL3933880

SCHEMBL3933880

O=C1SCCN1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11983441 0.74 INMT (0.41) —
SCHEMBL6299340 0.73 — —
SCHEMBL11758314 0.73 — —
SCHEMBL15330621 0.73 — —
SCHEMBL12862581 0.71 PIK3CD (0.47) —
SCHEMBL15330853 0.70 INMT (0.34) —
SCHEMBL8775918 0.69 MGLL (0.43) —
SCHEMBL12635490 0.68 GSK3B (0.45) —
SCHEMBL9514131 0.67 ALDH1A1 (0.60) —
SCHEMBL3965014 0.67 MAPT (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041128-A2 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS Allergan, Inc. (US) 2009-04-01 — — EP disclosed
WO-2007146856-A2 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS ALLERGAN, INC. (US) 2007-12-21 — — WO disclosed
Send feedback